Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1191 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Gumlink takes over 50% stake in Tab Labs

The joint venture is among the first initiatives in Gumlink’s nutraceutical strategy for the future involving strategic collaborations with various industry partners, as announced in January this year.

AstraZeneca launches thyroid cancer drug in US

AstraZeneca is in talks with relevant authorities on a trade name and is currently referring to the treatment by its generic name, vandetanib. AstraZeneca Specialty Care vice president

Oxford Nanopore obtains £25m funds from investors

The Oxford Nanopore platform technology, GridION, consists of a scalable modular instrument and self-contained consumable cartridge. GridION is adaptable for the analysis of different types of molecules including